TUOXIN PHARM GP COTUOXIN PHARM GP COTUOXIN PHARM GP CO

TUOXIN PHARM GP CO

No trades
See on Supercharts

301089 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Tuoxin Pharmaceutical Group Co., Ltd. engages in the research, development, production and sale of chemical synthetic biological fermented nucleoside APIs and pharmaceutical intermediates. It offers series of nucleoside (nucleotide) products including pyrimidine series, purine series, nucleotide series and nucleoside series, including citicoline sodium, ribavirin, inosine, cytosine, 5-fluorocytosine, cytidine and other raw materials and pharmaceutical intermediates. The company's products mainly covering antiviral, anti-tumor and nervous system medicine n terms of production management system. Xinxiang Tuoxin Pharmaceutical was founded on August 2, 2001 and is headquartered in Xinxiang, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
301089 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company